Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

Monoclonal antibody ibalizumab maintains HIV suppression for nearly a decade

News
29 October 2020
Weight gain & lipodystrophy

More Research Points to Weight Increases on TAF-Containing HIV Treatment

Editor's pick
TheBodyPro
27 October 2020
Injectable & long-acting HIV treatment

Similar benefits and barriers to injectables for HIV prevention and treatment reported by US women

News
21 October 2020
Drug interactions & pharmacokinetics

Study finds diabetes is associated with a 25% reduction in concentration of tenofovir in blood spot samples, but what are the causes and consequences?

News
20 October 2020
Changing treatment

Switching HIV Regimen to Biktarvy Is Safe and Effective for the Long Term

Editor's pick
POZ
19 October 2020
Treatment guidelines

Perinatal Exposure to HIV Requires Specialized, Coordinated Care

Editor's pick
American Journal of Managed Care
19 October 2020
Injectable & long-acting HIV treatment

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

Editor's pick
ViiV Healthcare press release
16 October 2020
Clinical trials

Biological, clinical and ethical imperatives for involving diverse women in HIV clinical trials

News
14 October 2020
Resistance

Multidrug Resistance Still Boosts Death Risk in 31,000-Person Italian Study

Editor's pick
NATAP
13 October 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
People with limited treatment options

Patients with HIV and four-class drug resistance have high disease burden

Editor's pick
Healio
11 October 2020
Injectable & long-acting HIV treatment

Long-acting injectables work without oral lead-in period

News
11 October 2020
New & experimental HIV treatments

Capsid inhibitor lenacapavir, dosed six-monthly, has high barrier to drug resistance and no cross-resistance to other classes

Editor's pick
i-Base
9 October 2020
New & experimental HIV treatments

Islatravir plus doravirine remains effective at 96 weeks

News
9 October 2020
Coronavirus

BHIVA ‘2nd COVID peak’ guidance for HIV clinics - plain English version

Editor's pick
BHIVA
8 October 2020
Weight gain & lipodystrophy

Weight gain after switch to an integrase inhibitor does not boost 'bad fat'

News
7 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Injectable & long-acting HIV treatment

Injectable HIV therapy should save money if adherence is better than to oral therapies

News
7 October 2020
Weight gain & lipodystrophy

Weight gain on HIV treatment: what is normal, and what is harmful?

News
7 October 2020
Injectable & long-acting HIV treatment

Two-thirds of people living with HIV would like to try injectable treatment, according to European survey

News
5 October 2020
Weight gain & lipodystrophy

Genetics may contribute to weight gain after switching from efavirenz to an integrase inhibitor

News
2 October 2020
Clinical trials

No more excuses: Making HIV research work for women

Editor's pick
Sophia Forum
29 September 2020
Diabetes

HIV drugs could prevent diabetes, study suggests

Editor's pick
EurekAlert
24 September 2020
Adherence

Tanzania: Financial incentives improve HIV viral suppression, retention in care

Editor's pick
Healio
18 September 2020